OspA vaccine

OspA vaccine

Infectious disease A vaccine containing recombinant outer-surface protein A of B burgdorferi, the Lyme disease agent. See Borrelia burgdorferi, Lyme disease.
Mentioned in ?
References in periodicals archive ?
Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: A double-blind, randomised, dose-escalation phase 1/2 trial.
A novel multivalent OspA vaccine against Lyme borreliosis is safe and immunogenic in an adult population previously infected with Borrelia burgdorferi Sensu Lato.
com for individuals vaccinated with the recombinant OspA vaccine.